Intra-Cellular Therapies Inc

Company Snapshot
430 East 29th Street
New York, NY 10016
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 561
https://www.intracellulartherapies.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$20,635,724
$73,673,285
$228,689,000
Operating Income
($231,227,631)
($285,688,125)
($263,626,000)
Net Income
($227,005,663)
($284,125,666)
($256,256,000)
2020
Gross Profit
$20,635,724
Operating Income
($231,227,631)
Net Income
($227,005,663)
2021
Gross Profit
$73,673,285
Operating Income
($285,688,125)
Net Income
($284,125,666)
2022
Gross Profit
$228,689,000
Operating Income
($263,626,000)
Net Income
($256,256,000)
The above data on Intra-Cellular Therapies Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Sharon Mates
Chairman of the Board, President and Chief Executive Officer
$2,207,902
$6,999,988
$24,967
$9,232,857
Sharon Mates
$9,232,857
Chairman of the Board, President and Chief Executive Officer
Mark Neumann
Executive Vice President and Chief Commercial Officer
$977,452
$2,499,971
$20,906
$3,498,329
Mark Neumann
$3,498,329
Executive Vice President and Chief Commercial Officer
Michael Halstead
Executive Vice President General Counsel and Secretary
$964,455
$2,499,971
$19,196
$3,483,622
Michael Halstead
$3,483,622
Executive Vice President General Counsel and Secretary
Suresh Durgam
Executive Vice President and Chief Medical Officer
$949,639
$2,499,971
$12,197
$3,461,807
Suresh Durgam
$3,461,807
Executive Vice President and Chief Medical Officer
Lawrence Hineline
Principal Accounting Officer, Senior Vice President Finance, Chief Financial Officer, Treasurer and Assistant Secretary
$798,086
$1,899,945
$22,447
$2,720,478
Lawrence Hineline
$2,720,478
Principal Accounting Officer, Senior Vice President Finance, Chief Financial Officer, Treasurer and Assistant Secretary
Intra-Cellular Therapies Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us